Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JAMA Network Open|January 29, 2026
High-Deductible Health Plans and Mortality Among Cancer SurvivorsJustin M Barnes, Arjun Gupta, Meera Ragavan, et al.JCO Oncology Practice|April 7, 2021
Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care SystemsDivya A Parikh, Meera Ragavan, Ritika Dutta, et al.Ecancermedicalscience|July 12, 2026
Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in MexicoAndres Meraz-Brenez, Enrique Soto-Perez-De-Celis, Roberta Demichelis-Gomez, et al.Journal of Thoracic Disease|December 11, 2025
The role of targetable biomarker alterations in overall survival for non-small cell lung cancer (NSCLC) in a large integrated health systemAlberto Jarrin Lopez, Lori C Sakoda, Haley I Tupper, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 17, 2024
Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral programDivya A Parikh, Gladys M Rodriguez, Meera Ragavan, et al.BMJ Open|February 8, 2022
Estimating maternity ward birth attendant time use in India: a microcosting studyKatherine T Lofgren, Lauren Bobanski, Danielle E Tuller, et al.International Urogynecology Journal|January 28, 2023
Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodologyRajesh Taneja, Sanjay Pandey, Shivam Priyadarshi, et al.Facts, Views & Vision in Obgyn|March 19, 2026
Port placement and patient-specific docking strategies for robotic hysterectomy with the Hugo™ RAS system: an international Delphi consensusDiego Raimondo, Enrico Pazzaglia, Helder Ferreira, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.Pageof 2